Oxnard GR - Search Results

1

Acquired EGFR C797S mutation mediates resistance to AZD9291 in non-small cell lung cancer harboring EGFR T790M.

Thress KS, Paweletz CP, Felip E, Cho BC, Stetson D, Dougherty B, Lai Z, Markovets A, Vivancos A, Kuang Y, Ercan D, Matthews SE, Cantarini M, Barrett JC, Jänne PA, Oxnard GR. Thress KS, et al. Among authors: oxnard gr. Nat Med. 2015 Jun;21(6):560-2. doi: 10.1038/nm.3854. Epub 2015 May 4. Nat Med. 2015. PMID: 25939061 Free PMC article.

2

Acquired resistance to EGFR tyrosine kinase inhibitors in EGFR-mutant lung cancer: distinct natural history of patients with tumors harboring the T790M mutation.

Oxnard GR, Arcila ME, Sima CS, Riely GJ, Chmielecki J, Kris MG, Pao W, Ladanyi M, Miller VA. Oxnard GR, et al. Clin Cancer Res. 2011 Mar 15;17(6):1616-22. doi: 10.1158/1078-0432.CCR-10-2692. Epub 2010 Dec 6. Clin Cancer Res. 2011. PMID: 21135146 Free PMC article. Clinical Trial.

3

New strategies in overcoming acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors in lung cancer.

Oxnard GR, Arcila ME, Chmielecki J, Ladanyi M, Miller VA, Pao W. Oxnard GR, et al. Clin Cancer Res. 2011 Sep 1;17(17):5530-7. doi: 10.1158/1078-0432.CCR-10-2571. Epub 2011 Jul 20. Clin Cancer Res. 2011. PMID: 21775534 Free PMC article. Review.

4

EGFR exon 19 insertions: a new family of sensitizing EGFR mutations in lung adenocarcinoma.

He M, Capelletti M, Nafa K, Yun CH, Arcila ME, Miller VA, Ginsberg MS, Zhao B, Kris MG, Eck MJ, Jänne PA, Ladanyi M, Oxnard GR. He M, et al. Among authors: oxnard gr. Clin Cancer Res. 2012 Mar 15;18(6):1790-7. doi: 10.1158/1078-0432.CCR-11-2361. Epub 2011 Dec 21. Clin Cancer Res. 2012. PMID: 22190593 Free PMC article.

5

KRAS wild-type lung cancer: a moving target in an era of genotype migration.

Oxnard GR, Jänne PA. Oxnard GR, et al. J Clin Oncol. 2012 Sep 20;30(27):3322-4. doi: 10.1200/JCO.2012.43.2740. Epub 2012 Aug 6. J Clin Oncol. 2012. PMID: 22869875 No abstract available.

6

Strategies for overcoming acquired resistance to epidermal growth factor receptor: targeted therapies in lung cancer.

Oxnard GR. Oxnard GR. Arch Pathol Lab Med. 2012 Oct;136(10):1205-9. doi: 10.5858/arpa.2012-0254-RA. Arch Pathol Lab Med. 2012. PMID: 23020725 Free article. Review.

7

Natural history and molecular characteristics of lung cancers harboring EGFR exon 20 insertions.

Oxnard GR, Lo PC, Nishino M, Dahlberg SE, Lindeman NI, Butaney M, Jackman DM, Johnson BE, Jänne PA. Oxnard GR, et al. J Thorac Oncol. 2013 Feb;8(2):179-84. doi: 10.1097/JTO.0b013e3182779d18. J Thorac Oncol. 2013. PMID: 23328547 Free PMC article.

8

New targetable oncogenes in non-small-cell lung cancer.

Oxnard GR, Binder A, Jänne PA. Oxnard GR, et al. J Clin Oncol. 2013 Mar 10;31(8):1097-104. doi: 10.1200/JCO.2012.42.9829. Epub 2013 Feb 11. J Clin Oncol. 2013. PMID: 23401445 Free PMC article. Review.

9

Power in numbers: meta-analysis to identify inhibitor-sensitive tumor genotypes.

Oxnard GR, Jänne PA. Oxnard GR, et al. Clin Cancer Res. 2013 Apr 1;19(7):1634-6. doi: 10.1158/1078-0432.CCR-13-0169. Epub 2013 Feb 12. Clin Cancer Res. 2013. PMID: 23403632 Free PMC article.

10

Acquired resistance to targeted therapies in advanced non-small cell lung cancer: new strategies and new agents.

West H, Oxnard GR, Doebele RC. West H, et al. Among authors: oxnard gr. Am Soc Clin Oncol Educ Book. 2013:10.1200/EdBook_AM.2013.33.e272. doi: 10.14694/EdBook_AM.2013.33.e272. Am Soc Clin Oncol Educ Book. 2013. PMID: 23714521 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

201 results

Search Page

Filters